Home > Pregnancy and opioid use: strategies for treatment, EMCDDA Papers.

European Monitoring Centre for Drugs and Drug Addiction. (2014) Pregnancy and opioid use: strategies for treatment, EMCDDA Papers. Luxembourg: Publications Office of the European Union.

[img]
Preview
PDF (Full report) - Published Version
527kB

Illicit opioid consumption during pregnancy brings with it the risk of an increase in obstetric complications for the mother and a range of potential dangers for the child, both before and after birth. The primary goal when treating opioid dependence in pregnant women is to stabilise the patient and psychosocially assisted opioid substitution treatment is the preferred first-line therapy for this group.

Several combinations of substitution medicines and psychosocial approaches are available. This paper reviews methadone, buprenorphine and slow-release oral morphine, used in a range of combinations with cognitive behavioural approaches and contingency management in order to identify the strengths of each medicine and method.


Date:2014
Pages:34 p.
Publisher:Publications Office of the European Union
Corporate Creators:European Monitoring Centre for Drugs and Drug Addiction
Place of Publication:Luxembourg
EndNote:View
Accession Number:HRB (Electronic Only)
Related URLs:
Subjects:B Substances > Opioids (opiates)
E Concepts in biomedical areas > Pregnancy
E Concepts in biomedical areas > Pregnancy > Reproductive effects of substance use
J Health care, prevention and rehabilitation > Treatment and maintenance > Treatment factors
T Demographic characteristics > Pregnant woman

Repository Staff Only: item control page